About this activity
Learning Objectives
Through real-world clinical cases, our panel of experts will examine the current use of HIFU for the treatment of localized prostate cancer (PCa) and discuss potential practice changes on the horizon in light of emerging clinical data and novel technologies. Throughout the discussion, the panel will analyze guideline recommendations and contrast the use of HIFU and other focal therapies for PCa treatment in different regions
This session is supported by SIU Congress Contributor EDAP TMS.
This session is supported by SIU Congress Contributor EDAP TMS.
Upon completion of this activity, participants should be able to:
- Review the current implementation of focal HIFU therapy for localized PCa, with a focus on differences in HIFU adoption in different countries.
- Examine alternative focal therapy approaches currently used in the clinical practice to manage localized disease.
- Analyze advances in HIFU technology and their impact on treatment decision-making, with emphasis on oncologic control and patient quality of life.
- iscuss current challenges limiting the adoption of focal HIFU therapy in the clinical practice, including differences in guideline recommendations.
SYMP-21: Luncheon Symposium: Focal HIFU Therapy in Prostate Cancer: Practice Changes on the Horizon?
SIU Academy®. Faculty / Presenters . 11/12/21; 347492
Topic: Focal therapy
Rafael Sanchez-Salas
Franck Bladou
Affiliations:
University Hospital Pellegrin, Bordeaux, France
University Hospital Pellegrin, Bordeaux, France
Pascal Rischmann
Martin Schostak
{{ help_message }}
{{filter}}